Avidity Corp (RNA) - Periode bali modal bisnis
Avidity Biosciences leads in muscle therapy thanks to a unique RNA molecule delivery method. The business's price-to-earnings ratio cuts through market noise, demonstrating the real payback period, where the value of -16.30 reflects this status. Conjugate patents protect the company from pharma behemoths, while the clinical portfolio scaling strategy paves the way for the imminent commercial launch of drugs.
Rincian metrik komprehensif lan analitis Avidity (RNA)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi pasar:
- data kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Avidity Biosciences|RNA - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Avidity Corp|RNA - Gunggung utang perusahaan|Utang-utang marang aset resik Avidity Biosciences, Inc.|RNA - Utang jangka dawa perusahaan|Utang jangka cendhak Avidity Biosciences|Koefisien jangkoan perantara aviditybiosciences.com
- informasi bathi lan kelipatan valuasi:
RNA - Bathi resik|Bathi mangsa ngarep Avidity Biosciences|RNA - Pangali P/E|Kapitalisasi marang proyeksi bathi Avidity Biosciences Inc|RNA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Avidity Biosciences, Inc.|RNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Avidity Biosciences|RNA - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan aviditybiosciences.com|RNA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Avidity Biosciences
Ringkesan analisis perusahaan:Avidity Biosciences
Avidity Biosciences (RNA) specializes in the development of RNA therapies and is currently in the clinical trial stage with no current revenue or profit. An analysis of the company's median P/E allows for an assessment of market expectations regarding future earnings, while abnormal fluctuations in this indicator serve as a stress test of the issuer's financial stability, signaling risks of capital freeze to investors in the absence of operational cash flow.
Analisis perusahaan pesaing
Pangali rega marang bathi TEM (Tempus AI Inc)|Pangali P/E QGEN|Periode bali modal bisnis Ionis Pharmaceuticals, Inc.|Repligen Corp. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik CRSP (CRISPR)|WGS: Koefisien rega marang bathi|Kapitalisasi marang bathi ultragenyx.com|BEAM (Beam Therapeutics) - Koefisien rega marang bathi|Sarepta Therapeutics - Nilai perusahaan marang bathi resik|TWST (Twist Bio) - Pangali P/E|Rasio rega marang bathi TXG|Pangali P/E NTLA|Periode bali modal bisnis stoketherapeutics.com|Rasio rega marang bathi BioLife Solutions BLFS|Wave Life Sciences Ltd (WVE) - Kapitalisasi marang bathi|MAZE - Rasio rega marang bathi|Periode bali modal bisnis Sionna Corp SION|PRME: Pangali P/E|Koefisien rega marang bathi tayshagtx.com|QURE (uniQure) - Pangali P/E|MeiraGTx Holdings (MGTX) - Periode bali modal bisnis|Pangali P/E RGNX|SLDB - Kapitalisasi marang bathi|Rasio rega marang bathi Ocugen, Inc. OCGN|PACB: Pangali rega marang bathi|Benitec Biopharma - Pangali P/E|Design Therapeutics Inc (DSGN) - Koefisien rega marang bathi|RCKT: Pangali P/E|Kapitalisasi marang bathi 4D Molecular Corp (FDMT)|Rasio rega marang bathi Lexeo Therapeutics Inc.|Korro Bio, Inc (KRRO) - Periode bali modal bisnis|Rasio rega marang bathi Editas Medicine (EDIT)|SLN (Silence Therapeutics PLC) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi ProQR Therapeutics PRQR|CDXS: Pangali rega marang bathi|Sangamo Therapeutics - Pangali P/E|NAUT - Pangali P/E|MGX: Pangali P/E|Pangali rega marang bathi DTIL|Rasio rega marang bathi Generation Bio Co|Pangali rega marang bathi BOLD (Boundless Bio Inc)|Pangali P/E XCUR|Pangali P/E imunon.com (IMNN)|Pangali P/E PHIO (Phio Pharmaceuticals Corp.)|Pangali P/E Mustang Bio Inc MBIO|RNAZ: Koefisien rega marang bathi|BNGO: Rasio rega marang bathi|APDN: Pangali P/E|BLUE - Periode bali modal bisnis|IPA (ImmunoPrecise Antibodies Ltd) - Pangali P/E|Pangali rega marang bathi OMGA (Omega Therapeutics Inc)|Pangali P/E OMIC|Periode bali modal bisnis Regulus|Syros Pharmaceuticals - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik TBIO (telesisbio.com)|TCON: Koefisien rega marang bathi|Kapitalisasi marang bathi Unity Biotechnology Inc.
